Immunoregulation of allergic contact dermatitis

被引:45
作者
Girolomoni, G [1 ]
Gisondi, P [1 ]
Ottaviani, C [1 ]
Cavani, A [1 ]
机构
[1] IRCCS, Ist Dermopat Immacolata, I-00167 Rome, Italy
关键词
allergic contact dermatitis; regulatory T cells; interleukin; 10; CD4(+)CD25(+) T cells;
D O I
10.1111/j.1346-8138.2004.tb00671.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Allergic contact dermatitis (ACD) to haptens can serve as a valuable paradigm for understanding the physiopathology of T cell mediated immune responses. In sensitized individuals, exposure to the relevant hapten initiates clinical expression of ACD, which depends on the rapid activation of specific T cells. Mechanisms of tissue damage include direct cytotoxicity against keratinocytes, mostly mediated by CD8(+) T cells, and T cell release of cytokines, which amplify the inflammatory response by targeting resident skin cells. The expression of ACD is actively regulated by specialized subsets of T lymphocytes with suppressive functions. In particular, T regulatory cells producing high levels of IL-10 suppress ACD by blocking the functions of dendritic cells. In contrast CD4(+)CD25(+) regulatory T cells prevent immunopathological reactions and maintain peripheral tolerance to haptens by acting via a cell-to-cell contact mechanism. Understanding the role of suppressor T cells and the requirements for their in vivo and in vitro expansion are critical steps for the development of specific desensitization protocols in hapten-allergic individuals. This information may also provide the basis for novel interventions in other immune-mediated diseases.
引用
收藏
页码:264 / 270
页数:7
相关论文
共 52 条
[1]   Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-γ- and interleukin-4-induced activation of human keratinocytes [J].
Albanesi, C ;
Scarponi, CS ;
Cavani, A ;
Federici, M ;
Nasorri, F ;
Girolomoni, G .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (01) :81-87
[2]   IL-4 enhances keratinocyte expression of CXCR3 agonistic chemokines [J].
Albanesi, C ;
Scarponi, C ;
Sebastiani, S ;
Cavani, A ;
Federici, M ;
De Pità, O ;
Puddu, P ;
Girolomoni, G .
JOURNAL OF IMMUNOLOGY, 2000, 165 (03) :1395-1402
[3]  
Albanesi C, 2001, J LEUKOCYTE BIOL, V70, P617
[4]   Tolerance to nickel: Oral nickel administration induces a high frequency of anergic T cells with persistent suppressor activity [J].
Artik, S ;
Haarhuis, K ;
Wu, XZ ;
Begerow, J ;
Gleichmann, E .
JOURNAL OF IMMUNOLOGY, 2001, 167 (12) :6794-6803
[5]   CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity [J].
Belkaid, Y ;
Piccirillo, CA ;
Mendez, S ;
Shevach, EM ;
Sacks, DL .
NATURE, 2002, 420 (6915) :502-507
[6]   Natural versus adaptive regulatory T cells [J].
Bluestone, JA ;
Abbas, AK .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (03) :253-257
[7]   Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis [J].
Cao, D ;
Malmström, V ;
Baecher-Allan, C ;
Hafler, D ;
Klareskog, L ;
Trollmo, C .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (01) :215-223
[8]   Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide [J].
Caramalho, I ;
Lopes-Carvalho, T ;
Ostler, D ;
Zelenay, S ;
Haury, M ;
Demengeot, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (04) :403-411
[9]   Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses [J].
Cavani, A ;
Nasorri, F ;
Prezzi, C ;
Sebastiani, S ;
Albanesi, C ;
Girolomoni, G .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 114 (02) :295-302
[10]   Human CD25+ regulatory T cells maintain immune tolerance to nickel in healthy, nonallergic individuals [J].
Cavani, A ;
Nasorri, F ;
Ottaviani, C ;
Sebastiani, S ;
De Pità, O ;
Girolomoni, G .
JOURNAL OF IMMUNOLOGY, 2003, 171 (11) :5760-5768